BMET-26: PHASE 2 STUDY OF VB-111, AN ANTI-CANCER GENE THERAPY, AS MONOTHERAPY FOLLOWED BY COMBINATION OF VB-111 WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA
BMET-26:VB-111(一种抗癌基因疗法)单药治疗后联合贝伐珠单抗治疗复发性胶质母细胞瘤患者的II期研究
期刊:
影响因子:
doi:10.1016/j.virol.2015.07.024
Ying, Baoling; Toth, Karoly; Spencer, Jacqueline F; Aurora, Rajeev; Wold, William S M; Kato, Yuki; Scharnweber, Rudi; Inagaki, Akhito; Kamijima, Shuichi; Hickey, Michelle; Lisiero, Dominique; Hermann, Kip; Soto, Horacio; Antonios, Joe; Sedighim, Shaina; Okada, Hideho; Liau, Linda; Klatzmann, David; Prins, Robert; Kashara, Noriyuki; Brenner, Andrew; Cohen, Yael; Vredenburgh, James; Peters, Katherine; Nayak, Lakshmi; Blumenthal, Deborah; Bokstein, Felix; Breitbart, Eyal; Bangio, Livnat; Sher, Naamit; Harats, Dror; Wen, Patrick